Skip to main content

Table 4 Pain scores at different timepoints as assessed by CBPI

From: Palmitoyl-glucosamine co-micronized with curcumin for maintenance of meloxicam-induced pain relief in dogs with osteoarthritis pain

 

Total pain score

PSS

PIS

T4

T5

V3

T4

T5

V3

T4

T5

V3

n

36

29

29

36

29

29

36

29

29

Range

0–49

8–37

0–72

0–3.8

1–3.8

0–7

0–5.7

0.5–4.2

0–7.3

Median

19

18

21

1.8

1.8

2.0

1.9

1.7

1.8

IQR

(16 to 26.5)

(15 to 26)

(7 to 33)

(1.8 to 2.6)

(1.8 to 2.3)

(0.8 to 3)

(1.5 to 3)

(1.3 to 2.8)

(0.7 to 3.3)

Mean

21.8

20.7

22.4

2.1

2.0

2.2

2.3

2.1

2.3

StdErr

1.6

1.5

3.5

0.1

0.1

0.3

0.2

0.2

0.4

  1. Total pain score, pain severity and pain interference scores on CBPI as registered at the different timepoints of the study are detailed. No statistically significant changes were observed at any time
  2. Abbreviations: PIS Pain Interference Score, PSS Pain Severity Score, T4 and T5 Fourth and fifth telephone interviews, respectively, V3 Final visit (see Fig. 4 for timeline)